Literature DB >> 28264850

First Report of the Carbapenemase Gene blaOXA-499 in Acinetobacter pittii.

Roshan D'Souza1, Naina Adren Pinto1,2, Paul G Higgins3,4, Insik Hwang1,2, Dongeun Yong5, Jongrak Choi1, Kyoungwon Lee1, Yunsop Chong1.   

Abstract

We identified the carbapenemase gene blaOXA-499, a variant of blaOXA-143, from a clinical isolate of Acinetobacter pittii for the first time. OXA-499 shared 93.1% amino acid identity with OXA-143, and the gene was located on the chromosome. By cloning the OXA-499-encoding gene into the pWH1266 vector and transforming it into susceptible Acinetobacter spp., we were able to show that OXA-499 confers resistance to carbapenems.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Acinetobacter pittii; OXA-143-like; OXA-499; carbapenemase resistant

Mesh：

Substances：

Year:  2017        PMID： 28264850      PMCID： PMC5404604          DOI： 10.1128/AAC.02676-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  First report of OXA-23 carbapenemase in clinical isolates of Acinetobacter species in the Irish Republic.

Authors:  T W Boo; F Walsh; B Crowley
Journal:  J Antimicrob Chemother       Date:  2006-08-17       Impact factor: 5.790

2.  Carriage of OXA-58 but not of OXA-51 beta-lactamase gene correlates with carbapenem resistance in Acinetobacter baumannii.

Authors:  Athanassios Tsakris; Alexandros Ikonomidis; Spyros Pournaras; Nicholas Spanakis; Antonios Markogiannakis
Journal:  J Antimicrob Chemother       Date:  2006-09-22       Impact factor: 5.790

3.  First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.

Authors:  Delphine Girlich; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

4.  Characterization of blaOXA-143 variants in Acinetobacter baumannii and Acinetobacter pittii.

Authors:  Esther Zander; Rémy A Bonnin; Harald Seifert; Paul G Higgins
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

5.  OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain.

Authors:  G Bou; A Oliver; J Martínez-Beltrán
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

6.  A 10-min method for preparation of highly electrocompetent Pseudomonas aeruginosa cells: application for DNA fragment transfer between chromosomes and plasmid transformation.

Authors:  Kyoung-Hee Choi; Ayush Kumar; Herbert P Schweizer
Journal:  J Microbiol Methods       Date:  2005-06-28       Impact factor: 2.363

7.  Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.

Authors:  Young Kyoung Park; Sook-In Jung; Kyong-Hwa Park; Su Hwan Kim; Kwan Soo Ko
Journal:  Int J Antimicrob Agents       Date:  2011-10-12       Impact factor: 5.283

8.  Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina.

Authors:  S Brown; H K Young; S G B Amyes
Journal:  Clin Microbiol Infect       Date:  2005-01       Impact factor: 8.067

9.  Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005-2009).

Authors:  X Schleicher; P G Higgins; H Wisplinghoff; B Körber-Irrgang; M Kresken; H Seifert
Journal:  Clin Microbiol Infect       Date:  2012-10-03       Impact factor: 8.067

10.  Identification of 50 class D β-lactamases and 65 Acinetobacter-derived cephalosporinases in Acinetobacter spp.

Authors:  Bruno Périchon; Sylvie Goussard; Violaine Walewski; Lenka Krizova; Gustavo Cerqueira; Cheryl Murphy; Michael Feldgarden; Jennifer Wortman; Dominique Clermont; Alexandr Nemec; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.